BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19670414)

  • 1. Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels.
    Haring R; Wallaschofski H; Nauck M; Dörr M; Baumeister SE; Völzke H
    Hepatology; 2009 Nov; 50(5):1403-11. PubMed ID: 19670414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between hepatic steatosis and serum liver enzyme levels with atrial fibrillation in the general population: The Study of Health in Pomerania (SHIP).
    Markus MR; Meffert PJ; Baumeister SE; Lieb W; Siewert U; Schipf S; Koch M; Kors JA; Felix SB; Dörr M; Targher G; Völzke H
    Atherosclerosis; 2016 Feb; 245():123-31. PubMed ID: 26722832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
    Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
    Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population.
    Ruhl CE; Everhart JE
    Gastroenterology; 2009 Feb; 136(2):477-85.e11. PubMed ID: 19100265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors.
    Kim DJ; Noh JH; Cho NH; Lee BW; Choi YH; Jung JH; Min YK; Lee MS; Lee MK; Kim KW
    Diabet Med; 2005 Sep; 22(9):1134-40. PubMed ID: 16108838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. γ-Glutamyl Transferase Is Associated with Mortality Outcomes Independently of Fatty Liver.
    Sung KC; Ryu S; Kim BS; Cheong ES; Park DI; Kim BI; Kwon MJ; Wild SH; Byrne CD
    Clin Chem; 2015 Sep; 61(9):1173-81. PubMed ID: 26152752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-glutamyltransferase and risk of cardiovascular disease mortality in people with and without diabetes: pooling of three British Health Surveys.
    Kengne AP; Czernichow S; Stamatakis E; Hamer M; Batty GD
    J Hepatol; 2012 Nov; 57(5):1083-9. PubMed ID: 22796154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γ-Glutamyltransferase and cancer risk: The Korean cancer prevention study.
    Mok Y; Son DK; Yun YD; Jee SH; Samet JM
    Int J Cancer; 2016 Jan; 138(2):311-9. PubMed ID: 26111622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Serum Gamma-glutamyl Transpeptidase Levels and Fatty Liver Strongly Predict the Presence of Carotid Plaque.
    Toshikuni N; Asaji T; Nakanishi Y; Nagasawa SY; Uenishi H; Tsutsumi M
    J Atheroscler Thromb; 2015; 22(10):1051-60. PubMed ID: 25891209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortality.
    Onat A; Can G; Kaya A; Akbaş T; Özpamuk-Karadeniz F; Şimşek B; Çakır H; Yüksel H
    World J Gastroenterol; 2015 Dec; 21(48):13555-65. PubMed ID: 26730168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fatty liver index is associated with increased mortality in subjects referred to coronary angiography.
    Lerchbaum E; Pilz S; Grammer TB; Boehm BO; Stojakovic T; Obermayer-Pietsch B; März W
    Nutr Metab Cardiovasc Dis; 2013 Dec; 23(12):1231-8. PubMed ID: 23557879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased γ-glutamyl transferase levels predict early mortality in patients with acute pulmonary embolism.
    Zorlu A; Yucel H; Bektasoglu G; Turkdogan KA; Eryigit U; Sarikaya S; Ege MR; Tandogan I; Yilmaz MB
    Am J Emerg Med; 2012 Jul; 30(6):908-15. PubMed ID: 22386346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
    Unalp-Arida A; Ruhl CE
    Hepatology; 2016 Apr; 63(4):1170-83. PubMed ID: 26663021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty liver index and mortality: the Cremona study in the 15th year of follow-up.
    Calori G; Lattuada G; Ragogna F; Garancini MP; Crosignani P; Villa M; Bosi E; Ruotolo G; Piemonti L; Perseghin G
    Hepatology; 2011 Jul; 54(1):145-52. PubMed ID: 21488080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic steatosis is associated with aortic valve sclerosis in the general population: the Study of Health in Pomerania (SHIP).
    Markus MR; Baumeister SE; Stritzke J; Dörr M; Wallaschofski H; Völzke H; Lieb W
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1690-5. PubMed ID: 23685558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
    Lee DS; Evans JC; Robins SJ; Wilson PW; Albano I; Fox CS; Wang TJ; Benjamin EJ; D'Agostino RB; Vasan RS
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):127-33. PubMed ID: 17095717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample.
    Völzke H; Nauck M; Rettig R; Dörr M; Higham C; Brabant G; Wallaschofski H
    Eur J Endocrinol; 2009 Nov; 161(5):705-13. PubMed ID: 19690083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Gamma-Glutamyltransferase Levels Predict Mortality in Patients With Peritoneal Dialysis.
    Park WY; Kim SH; Kim YO; Jin DC; Song HC; Choi EJ; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW; Kim YK
    Medicine (Baltimore); 2015 Aug; 94(31):e1249. PubMed ID: 26252286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alanine aminotransferase and gamma-glutamyl transferase have different dose-response relationships with risk of mortality by age.
    Oh CM; Won YJ; Cho H; Lee JK; Park BY; Jun JK; Koh DH; Ki M; Jung KW; Oh IH
    Liver Int; 2016 Jan; 36(1):126-35. PubMed ID: 26036985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography-The Ludwigshafen Risk and Cardiovascular Health Study.
    Stojakovic T; Scharnagl H; Trauner M; Pieske B; Wellnitz B; Seelhorst U; Schilling D; Winkelmann BR; Boehm BO; März W
    Atherosclerosis; 2010 Feb; 208(2):564-71. PubMed ID: 19695568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.